Tecan Group Croissance future
Future contrôle des critères 3/6
Tecan Group devrait augmenter ses bénéfices et son chiffre d'affaires de 50% et de 4.6% par an respectivement. Le BPA devrait croître de de 48% par an. Le rendement des capitaux propres devrait être 7.9% dans 3 ans.
Informations clés
50.0%
Taux de croissance des bénéfices
48.00%
Taux de croissance du BPA
| Life Sciences croissance des bénéfices | 19.2% |
| Taux de croissance des recettes | 4.6% |
| Rendement futur des capitaux propres | 7.86% |
| Couverture par les analystes | Good |
| Dernière mise à jour | 13 May 2026 |
Mises à jour récentes de la croissance future
Recent updates
Mise à jour du récit • May 02
TECN: Updated Discount Assumptions Will Shape Perceived Upside Potential
Tecan Group's analyst price target has been reduced by CHF 1 to CHF 136, as analysts factor in updated discount rate and valuation assumptions, along with modest adjustments to revenue growth, profit margin and future P/E inputs. Analyst Commentary Recent research points to a more cautious tone around Tecan Group, with reduced price targets reflecting reassessed assumptions on growth, profitability and valuation multiples.
Mise à jour du récit • Apr 18
TECN: AI Lab Collaboration And Execution Discipline Will Support Future Earnings
The analyst price target for Tecan Group has shifted slightly to around CHF 167, with recent CHF 1 and CHF 17 target reductions from different firms. These moves have led analysts to fine tune assumptions on discount rate, revenue growth, profit margin and future P/E, without changing the overall valuation picture in a major way.Mise à jour du récit • Apr 03
TECN: Mixed Research Views And 2026 Guidance Shape Forward Expectations
Analysts have trimmed their average price target on Tecan Group to CHF 205, a CHF 17 reduction from recent levels. This reflects updated views on discount rates, revenue growth, profit margins and future P/E assumptions following mixed target moves across the Street.Mise à jour du récit • Mar 20
TECN: AI Lab Collaboration Will Support Forward Efficiency Gains And Earnings
The updated analyst price target for Tecan Group moves to CHF 166.50 from CHF 192.57, reflecting mixed Street views as some analysts trim targets while others highlight support from higher assumed revenue growth and a slightly lower future P/E multiple. Analyst Commentary Recent Street research on Tecan Group points to a split view, with some analysts trimming price targets and others turning more constructive on the shares.Mise à jour du récit • Mar 05
TECN: Mixed Research Views And Investor Day Outlook Shape Future Expectations
Analysts have trimmed their price target for Tecan Group to CHF 137.00 from CHF 165.20, reflecting updated assumptions around discount rates, revenue growth, profit margins and future P/E. Recent research also includes both a Morgan Stanley target cut and target and rating adjustments from other firms.
Mise à jour du récit • Feb 19
TECN: Recent Upgrade And CHF 205 Goal Will Support Higher Long Term P/E
Analysts have nudged their price targets on Tecan Group slightly lower, with moves such as Morgan Stanley trimming its target by CHF 5 and others, including Bernstein and Berenberg, adjusting their outlooks. These revisions have led to only marginal changes in modeled fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.Mise à jour du récit • Feb 05
TECN: CFO Transition And Execution Will Support Higher Long Term P/E Potential
Analysts have nudged their price expectations for Tecan Group slightly higher, with the updated fair value estimate moving from CHF 334.71 to about CHF 335.08. This reflects small model adjustments to growth, margins and long term P/E assumptions after recent mixed target moves from banks that both lowered and raised their CHF based price targets.Mise à jour du récit • Jan 22
TECN: Execution And CFO Transition Will Support Upgraded Outlook And Medium Term Upside
Narrative Update The analyst price target for Tecan Group has been revised to CHF 205 from CHF 200. Analysts cite updated assumptions on growth, profitability and a higher future P/E multiple as the main factors behind this change.Mise à jour du récit • Jan 08
TECN: Efficiency Gains And Gradual Market Recovery Will Support Forward Earnings
Analysts have trimmed their price target on Tecan Group to about CHF 193 from around CHF 202, reflecting slightly lower fair value estimates, supported by recent target reductions such as the move to CHF 170 cited in Street research. Analyst Commentary Recent Street commentary around Tecan Group points to a more cautious stance, with price targets being reset closer to CHF 170, which sits below the trimmed average around CHF 193.Article d’analyse • Dec 23
Does Tecan Group (VTX:TECN) Have A Healthy Balance Sheet?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Mise à jour du récit • Dec 14
TECN: Medium Term Execution And CFO Transition Will Support Future Upside Potential
Analysts have lowered their price target on Tecan Group to CHF 170 from CHF 177, reflecting a slightly higher discount rate despite modestly improved revenue growth and profit margin expectations. Analyst Commentary Bullish analysts acknowledge the modest reduction in the price target but view the revised CHF 170 level as still supportive of upside potential from current trading levels, given improving fundamentals and execution.Mise à jour du récit • Nov 30
TECN: Efficiency Gains And Market Recovery Will Drive Forward Earnings Improvements
Analysts have reduced their price target for Tecan Group from CHF 177 to CHF 170. They cited revised market assumptions and modest adjustments to key financial forecasts as reasons for this change.Mise à jour du récit • Nov 16
TECN: Automation Demand And Partnerships Will Drive Earnings Recovery After 2026
Tecan Group: Analyst Price Target Reduced on Updated Outlook Analysts have lowered their fair value estimate for Tecan Group from CHF 205.98 to CHF 202.48. They cited slightly higher discount rates and tempered expectations for revenue growth and profit margins as reasons for the change.Article d’analyse • Nov 06
Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 90% Above Its Share Price
Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF261 Tecan Group's CHF138...Mise à jour du récit • Nov 01
TECN: Resilient Demand And Share Repurchase Program Will Drive Shareholder Value
The analyst price target for Tecan Group has been revised downward from CHF 177 to CHF 170. Analysts cite slightly softer revenue growth expectations and a modest increase in the discount rate in their updated assessments.Article d’analyse • Oct 22
Should You Investigate Tecan Group AG (VTX:TECN) At CHF150?
Tecan Group AG ( VTX:TECN ), is not the largest company out there, but it saw significant share price movement during...Mise à jour du récit • Oct 18
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Tecan Group's updated analyst fair value price target has been revised downward from CHF 215.73 to CHF 207.23. This change reflects cautious analyst views amid slower revenue growth and tightened profit margin expectations.Mise à jour du récit • Oct 04
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Analysts have adjusted their price target for Tecan Group downward, reducing the fair value estimate from CHF 220.47 to CHF 215.73. This change is due to a slight increase in the discount rate, although forecasts for revenue growth and profit margins have improved.Mise à jour du récit • Sep 05
Advanced Automation And Personalized Medicine Will Shape Healthcare's Future
Analysts have lowered their outlook for Tecan Group due to concerns over near-term margin pressure, cautious end-market demand, and delayed recovery in key segments, though the consensus price target remained unchanged at CHF220.47. Analyst Commentary Cautious sentiment due to anticipation of "soft" first-half financial results impacting near-term performance.Article d’analyse • Sep 04
Tecan Group (VTX:TECN) Has A Pretty Healthy Balance Sheet
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Article d’analyse • Aug 20
Weak Statutory Earnings May Not Tell The Whole Story For Tecan Group (VTX:TECN)
SWX:TECN 1 Year Share Price vs Fair Value Explore Tecan Group's Fair Values from the Community and select yours The...Article d’analyse • Aug 08
Tecan Group AG's (VTX:TECN) Intrinsic Value Is Potentially 81% Above Its Share Price
Key Insights Tecan Group's estimated fair value is CHF281 based on 2 Stage Free Cash Flow to Equity Current share price...Article d’analyse • Jul 21
Why We're Not Concerned About Tecan Group AG's (VTX:TECN) Share Price
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...Article d’analyse • May 28
At CHF170, Is Tecan Group AG (VTX:TECN) Worth Looking At Closely?
While Tecan Group AG ( VTX:TECN ) might not have the largest market cap around , it saw a significant share price rise...Article d’analyse • Apr 24
Is Tecan Group AG (VTX:TECN) Trading At A 26% Discount?
Key Insights Tecan Group's estimated fair value is CHF199 based on 2 Stage Free Cash Flow to Equity Tecan Group is...Article d’analyse • Apr 08
Tecan Group AG (VTX:TECN) Shares Slammed 25% But Getting In Cheap Might Be Difficult Regardless
To the annoyance of some shareholders, Tecan Group AG ( VTX:TECN ) shares are down a considerable 25% in the last...Article d’analyse • Apr 04
Here's Why Shareholders Should Examine Tecan Group AG's (VTX:TECN) CEO Compensation Package More Closely
Key Insights Tecan Group will host its Annual General Meeting on 10th of April Total pay for CEO Achim von Leoprechting...Article d’analyse • Apr 01
Is Tecan Group (VTX:TECN) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Nouveau récit • Mar 16
Expansion Into South Korea And FDA Approval To Support Future High-Value Medical Device Production
Expansion into South Korea and FDA approval in Malaysia bolster Tecan's production and revenue growth potential in medical devices.Article d’analyse • Jan 12
Tecan Group AG's (VTX:TECN) Share Price Could Signal Some Risk
When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 20x, you may consider...Article d’analyse • Dec 21
A Look At The Fair Value Of Tecan Group AG (VTX:TECN)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Tecan Group fair value estimate is CHF231 With CHF198 share...Article d’analyse • Oct 09
Tecan Group AG's (VTX:TECN) P/E Still Appears To Be Reasonable
With a price-to-earnings (or "P/E") ratio of 33.7x Tecan Group AG ( VTX:TECN ) may be sending very bearish signals at...Article d’analyse • Sep 21
These 4 Measures Indicate That Tecan Group (VTX:TECN) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Article d’analyse • Aug 16
Earnings Report: Tecan Group AG Missed Revenue Estimates By 8.8%
It's been a sad week for Tecan Group AG ( VTX:TECN ), who've watched their investment drop 13% to CHF280 in the week...Article d’analyse • Jun 14
Is Tecan Group (VTX:TECN) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Article d’analyse • Apr 20
Calculating The Fair Value Of Tecan Group AG (VTX:TECN)
Key Insights Tecan Group's estimated fair value is CHF409 based on 2 Stage Free Cash Flow to Equity Current share price...Article d’analyse • Apr 02
Tecan Group AG's (VTX:TECN) Business Is Yet to Catch Up With Its Share Price
With a price-to-earnings (or "P/E") ratio of 36.2x Tecan Group AG ( VTX:TECN ) may be sending very bearish signals at...Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2028 | 982 | 84 | 90 | 145 | 6 |
| 12/31/2027 | 930 | 71 | 73 | 125 | 8 |
| 12/31/2026 | 884 | 51 | 75 | 131 | 8 |
| 12/31/2025 | 882 | -111 | 103 | 138 | N/A |
| 9/30/2025 | 895 | -24 | 118 | 152 | N/A |
| 6/30/2025 | 907 | 63 | 134 | 165 | N/A |
| 3/31/2025 | 920 | 65 | 126 | 157 | N/A |
| 12/31/2024 | 934 | 68 | 118 | 149 | N/A |
| 9/30/2024 | 967 | 85 | 105 | 135 | N/A |
| 6/30/2024 | 1,000 | 101 | 93 | 122 | N/A |
| 3/31/2024 | 1,037 | 117 | 109 | 141 | N/A |
| 12/31/2023 | 1,074 | 132 | 126 | 161 | N/A |
| 9/30/2023 | 1,088 | 120 | 114 | 151 | N/A |
| 6/30/2023 | 1,102 | 109 | 101 | 140 | N/A |
| 3/31/2023 | 1,123 | 115 | 97 | 134 | N/A |
| 12/31/2022 | 1,144 | 121 | 92 | 128 | N/A |
| 9/30/2022 | 1,110 | 113 | 91 | 129 | N/A |
| 6/30/2022 | 1,077 | 105 | 89 | 129 | N/A |
| 3/31/2022 | 1,012 | 113 | 110 | 149 | N/A |
| 12/31/2021 | 947 | 122 | 130 | 170 | N/A |
| 9/30/2021 | 911 | 136 | 163 | 203 | N/A |
| 6/30/2021 | 875 | 150 | 195 | 237 | N/A |
| 3/31/2021 | 803 | 127 | 181 | 223 | N/A |
| 12/31/2020 | 731 | 104 | 167 | 208 | N/A |
| 9/30/2020 | 691 | 94 | 142 | 177 | N/A |
| 6/30/2020 | 651 | 84 | 118 | 146 | N/A |
| 3/31/2020 | 644 | 79 | 96 | 122 | N/A |
| 12/31/2019 | 637 | 73 | 75 | 99 | N/A |
| 9/30/2019 | 627 | 70 | N/A | 95 | N/A |
| 6/30/2019 | 616 | 67 | N/A | 90 | N/A |
| 3/31/2019 | 605 | 69 | N/A | 92 | N/A |
| 12/31/2018 | 594 | 71 | N/A | 93 | N/A |
| 9/30/2018 | 582 | 70 | N/A | 99 | N/A |
| 6/30/2018 | 570 | 69 | N/A | 106 | N/A |
| 3/31/2018 | 559 | 67 | N/A | 103 | N/A |
| 12/31/2017 | 549 | 66 | N/A | 99 | N/A |
| 9/30/2017 | 536 | 62 | N/A | 93 | N/A |
| 6/30/2017 | 523 | 57 | N/A | 86 | N/A |
| 3/31/2017 | 515 | 56 | N/A | 102 | N/A |
| 12/31/2016 | 506 | 55 | N/A | 119 | N/A |
| 9/30/2016 | 491 | 55 | N/A | 124 | N/A |
| 6/30/2016 | 476 | 55 | N/A | 129 | N/A |
| 3/31/2016 | 458 | 56 | N/A | 114 | N/A |
| 12/31/2015 | 440 | 57 | N/A | 99 | N/A |
| 9/30/2015 | 434 | 52 | N/A | 83 | N/A |
| 6/30/2015 | 427 | 48 | N/A | 67 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: TECN devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance plus rapide que le taux d'épargne ( 0.6% ).
Bénéfices vs marché: TECN devrait devenir rentable au cours des 3 prochaines années, ce qui est considéré comme une croissance supérieure à la moyenne du marché.
Croissance élevée des bénéfices: TECN devrait devenir rentable dans les 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de TECN ( 4.6% par an) devrait croître plus lentement que le marché de Swiss ( 4.9% par an).
Croissance élevée des revenus: Le chiffre d'affaires de TECN ( 4.6% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de TECN devrait être faible dans 3 ans ( 7.9 %).
Découvrir les entreprises en croissance
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/21 14:42 |
| Cours de l'action en fin de journée | 2026/05/21 00:00 |
| Les revenus | 2025/12/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Tecan Group AG est couverte par 18 analystes. 8 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Harry Gillis | Berenberg |
| Delphine Le Louet | Bernstein |
| Susannah Ludwig | Bernstein |